Cannabis-Based Drug for Dravet Syndrome Now Available in all 50 States
Epidiolex was the first cannabis-based drug approved in the United States. It was first recommended for FDA approval by an advisory committee in April of 2018. In June of this…
Words Matter: Key Things to Keep in Mind When Talking about Epilepsy
November is Epilepsy Awareness Month! Epilepsy is a central nervous system disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations, and sometimes loss of…
<a href="https://pixabay.com/users/Free-Photos/">Free-Photos</a> / Pixabay
The FDA is Modernising Their Drug Development Processes
In a recent statement, Scott Gottlieb, the Commissioner of the US Food and Drug Administration, has re-affirmed the organisation’s commitment to modernising drug regulatory pathways. New changes are hoped to…
<a href="https://pixabay.com/users/Skitterphoto/">Skitterphoto</a> / Pixabay
FDA Commissioner Releases Statement on Targeted Therapies, New Efficiency Measures, and Modernizing Development
According to a story from Pharma Voice, Dr. Scott Gottlieb, the current commissioner of the US Food and Drug Administration (FDA) has recently released a statement in regards to efforts…
<a href="https://pixabay.com/users/PublicDomainPictures/">PublicDomainPictures</a> / Pixabay
Two Phase 2 Clinical Studies of a Drug for Rare Epilepsies Have Been Initiated
Two Phase 2 clinical trials called ‘Elektra’ and ‘Arcade’ have been initiated. They will investigate the drug OV935/TAK-935 as a potential treatment for paediatric patients with rare epilepsies. For…
<a href="https://pixabay.com/users/stevepb/">stevepb</a> / Pixabay
Takeda and Ovid Have Provided an Update on the Clinical Development Program for an Investigational Anti-Epileptic Drug
Takeda Pharmaceutical Company Limited and Ovid Therapeutics have released an overview of the clinical development program for TAK-935/OV935, an investigational drug that is being developed as a potential anti-epileptic…
New Partnership May Have Implications for Those with Dravet, Alzheimer’s, Epilepsy, and More
According to Newswire, the two companies, BioMotiv and Cure Network Dolby Acceleration Partners (CNDAP) partnered up together in order to create small molecules that can potentially treat various neurological disorders, including…
<a href="https://pixabay.com/users/kkolosov/">kkolosov</a> / Pixabay
Three Planned Studies of an Experimental Drug to Treat Rare Epilepsies Have Been Announced
The organisations Takeda Pharmaceutical Company and Ovid Therapeutics are collaborating over the development of the experimental drug TAK-935/OV935 as a possible treatment for several rare epilepsy syndromes. Takeda has just…
<a href="https://pixabay.com/users/luvqs/">luvqs</a> / Pixabay
Treatment for Dravet Syndrome is Making Progress in Trials
According to a story from Reuters, the drug development company Zogenix, Inc. has announced in a recent statement that its investigational drug for the treatment of a rare type of…
<a href="https://pixabay.com/users/jniittymaa0/">jniittymaa0</a> / Pixabay
A Phase 3 Study Has Shown Encouraging Results for an Investigational Treatment for Dravet Syndrome
Zogenix, Inc has announced the top-line results from a Phase 3 study of the investigational drug ZX008 (low-dose fenfluramine hydrochloride) for the treatment of young patients with Dravet syndrome. The…
<a href="https://pixabay.com/users/7raysmarketing/">7raysmarketing</a> / Pixabay
First Drug Made From Cannabis Approved by the FDA For Dravet Syndrome and Lennox-Gastaut Syndrome
According to a story from the Washington Post, the US Food and Drug Administration (FDA) has cleared the approval of Epidiolex®, a solution whose active ingredient is a refined version…
A Few Helpful Tips for the Dravet Syndrome Community on Awareness Day
Saturday June 23rd is Dravet syndrome awareness day! Dravet syndrome is a rare genetic dysfunction of the brain (epileptic encephalopathy). It begins in the first year of life in an otherwise…
Most Epilepsy Patients Benefit From Current Medications, But Look Forward to New Treatments
According to a story from Scimex, a recent assessment of available treatments for Dravet syndrome and other types of epilepsy has reaffirmed that anticonvulsant medications are still the most effective…
source: pixabay.com
Scottish Mother Prepares to Obtain Cannabidiol Oil For Her Son With Rare Epilepsy
According to a story from edinburghnews.com, mother Karen Gray is about to seek access to cannabidiol oil for her five-year-old son, Murray, who has a rare type of epilepsy, Myoclonic Astatic…
source: pixabay.com
A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy
According to a story from statnews.com, a drug derived from substances originating in the cannabis plant may be nearing approval by the U.S. Food and Drug Administration. The drug is…
source: pixabay.com
An Experimental Drug Was Helping A Girl With Dravet Syndrome. Will She Lose Access After the Trial?
According to a recent story from CityNews Toronto, Alara Ozkose's Dravet syndrome was preventing her from being able to live a life that was even close to normal. She was…
UK Family Travels to The Netherlands To Find Treatment For Their Daughter With Dravet Syndrome
According to BelfastLive, Darren and Danielle Gibson, the parents of little six-year-old Sophia battling Dravet syndrome, traveled out of the country in search of the care she needs. For the…
ICYMI: GW Pharmaceuticals Gets FDA Acceptance Letter for New Drug Review
A little more hope is given to individuals suffering from Lennox-Gastaut syndrome and Dravet syndrome as GW Pharmaceuticals shared the U.S. FDA will indeed be accepting their application for potential…
source: pixabay.com
This New Treatment for Dravet Syndrome is Moving Forward
GW Pharmaceuticals reports that Epidiolex, a cannabidiol based drug, had its NDA (New Drug Application) accepted for priority review by the Food and Drug Administration (FDA). The drug is intended…
<a href="https://pixabay.com/users/Free-Photos/">Free-Photos</a> / Pixabay
November is Epilepsy Awareness Month – Dravet Syndrome
Zero. Nada. Zip. Usually having nothing isn't a good thing, but in the case of people with uncontrolled seizures--like those that occur with Dravet syndrome--zero (as in no seizures) is…
Source: www.pixabay.com
How Dravet Syndrome Barriers are Broken by Bonds
Knowing you’re not alone and connecting with others who share the same experience with Dravet syndrome can be incredibly valuable. Parenting a child with such a specific set of symptoms…
[Source: pixabay.com]
Medical Marijuana Movement Gets Shot in the Arm
Proponents of medicinal marijuana got a little more ammunition earlier this year according to a blogger on Scienceblogs. However, some have claimed that cannabinoids cure everything from glaucoma to gallbladder,…
What Do You Know About Cannabidiol Drug Interactions?
Recent studies have shown promising results that cannabidiol (CBD) helps relieve different forms of epileptic seizures like those from Lennox-Gastaut syndrome and Dravet syndrome. Lennox–Gastaut syndrome (LGS) is particularly severe, childhood…
Editor’s Choice: Soo Many Promising Results, Advancements and Treatment Options for the Rare Disease World!
TGIF Patient Worthians! This week we have promising results on promising results. First up is news on a Dravet syndrome treatment. Second is a Lupus Nephritis drug in the works! Third…
Source: pixabay.com
How This Pup Changed the Life of a Little Girl with Dravet Syndrome
Elizabeth couldn’t speak. She wasn’t expected to ever utter a word. She couldn’t read. She struggled to make trips outside of the house. Certain smells and loud sounds bothered her.…
- 1
- 2
